Открыть главное меню
Главная
Случайная
Войти
Настройки
О hpluswiki
Отказ от ответственности
hpluswiki
Найти
Редактирование:
Aging genes 10-29
(раздел)
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
==LRRK2== * {{medline-title |title=Accelerated telomere shortening independent of [[LRRK2]] variants in Chinese patients with Parkinson's disease. |date=29.10.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33122450 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655166 }} * {{medline-title |title=The effect of [[LRRK2]] loss-of-function variants in humans. |date=06.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32461697 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303015 }} * {{medline-title |title=Parkinson's disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging. |date=19.02.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32075681 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031993 }} * {{medline-title |title=Autophagy and [[LRRK2]] in the Aging Brain. |date=2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31920513 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928047 }} * {{medline-title |title=SerThr-PhosphoProteome of Brain from Aged [[PINK1]]-KO A53T-[[SNCA]] Mice Reveals pT1928-[[MAP1B]] and pS3781-[[ANK2]] Deficits, as Hub between Autophagy and Synapse Changes. |date=04.07.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31277379 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651490 }} * {{medline-title |title=Age-dependent accumulation of oligomeric [[SNCA]]/α-synuclein from impaired degradation in mutant [[LRRK2]] knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). |date=02.2020 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30983487 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984454 }} * {{medline-title |title=A Neuron-Glial Trans-Signaling Cascade Mediates [[LRRK2]]-Induced Neurodegeneration. |date=12.02.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30759389 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474846 }} * {{medline-title |title=Upregulation of the p53-p21 pathway by G2019S [[LRRK2]] contributes to the cellular senescence and accumulation of α-synuclein. |date=02.2019 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30712480 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422450 }} * {{medline-title |title=G2019S [[LRRK2]] mutation facilitates α-synuclein neuropathology in aged mice. |date=12.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30172844 |full-text-url=https://sci-hub.do/10.1016/j.nbd.2018.08.018 }} * {{medline-title |title=The Enzymatic Core of the Parkinson's Disease-Associated Protein [[LRRK2]] Impairs Mitochondrial Biogenesis in Aging Yeast. |date=2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29977190 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021522 }} * {{medline-title |title=Age-related pathology after adenoviral overexpression of the leucine-rich repeat kinase 2 in the mouse striatum. |date=06.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29550548 |full-text-url=https://sci-hub.do/10.1016/j.neurobiolaging.2018.02.008 }} * {{medline-title |title=[[LRRK2]] G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HT Receptor Upregulation in Mice. |date=14.02.2018 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29305532 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705874 }} * {{medline-title |title=Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice. |date=15.11.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29056298 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693787 }} * {{medline-title |title=Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in [[LRRK2]] G2019S knock-in mice. |date=20.09.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28930069 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633343 }} * {{medline-title |title=Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and [[LRRK2]] G2019S Parkinson's disease model mice challenged with lipopolysaccharide. |date=18.11.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28958936 |full-text-url=https://sci-hub.do/10.1016/j.bbrc.2017.09.129 }} * {{medline-title |title=Progression of pathology in [[PINK1]]-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation. |date=02.08.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28768533 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541666 }} * {{medline-title |title=Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S [[LRRK2]] mice. |date=14.03.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28292328 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351259 }} * {{medline-title |title=Combined [[LRRK2]] mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease. |date=18.01.2017 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28098219 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241661 }} * {{medline-title |title=[[LRRK2]] BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function. |date=01.03.2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26744332 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754049 }} * {{medline-title |title=Functional and Morphological Correlates in the Drosophila [[LRRK2]] loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration. |date=2016 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26727265 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699764 }} * {{medline-title |title=G2019S [[LRRK2]] and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system. |date=12.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26253900 |full-text-url=https://sci-hub.do/10.1007/s00702-015-1438-9 }} * {{medline-title |title=An early axonopathy in a h[[LRRK2]](R1441G) transgenic model of Parkinson disease. |date=10.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26192625 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640977 }} * {{medline-title |title=Mutations in [[LRRK2]] potentiate age-related impairment of autophagic flux. |date=11.07.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26159606 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702340 }} * {{medline-title |title=[11C]PBR28 PET imaging is sensitive to neuroinflammation in the aged rat. |date=08.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25833342 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528008 }} * {{medline-title |title=Changes in actin dynamics and F-actin structure both in synaptoneurosomes of [[LRRK2]](R1441G) mutant mice and in primary human fibroblasts of [[LRRK2]](G2019S) mutation carriers. |date=22.01.2015 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25301747 |full-text-url=https://sci-hub.do/10.1016/j.neuroscience.2014.09.070 }} * {{medline-title |title=Genetic and pharmacological evidence that G2019S [[LRRK2]] confers a hyperkinetic phenotype, resistant to motor decline associated with aging. |date=11.2014 |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25107341 |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194318 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)